Given the location of the cysteine residue in the microtubule binding domain, it could be plausible that the covalent attachment of CoA causes disruption to the association of tau to microtubules, diminishing its stabilizing effects and contributing to AD etiopathogenesis (as is seen in tau phosphorylation). This evidence concerns the gene MAPT and Alzheimer disease.